Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CureVac
Biotech
Xaira, Anthos, CureVac & more—Chutes & Ladders
Ousted former Stanford president to lead new billion-dollar biotech. Fresh off BMS buy, Karuna’s ex-CEO to helm Anthos. CureVac names new CBO.
Max Bayer
,
Gabrielle Masson
,
Andrea Park
Apr 26, 2024 8:30am
CureVac, chasing Moderna mRNA flu shot, hits similar problems
Apr 4, 2024 9:30am
CureVac touts COVID-19 vax data despite adverse events
Jan 5, 2024 11:16am
CureVac hand-picks mRNA flu vaccine but keeps data tucked away
Sep 12, 2023 10:45am
LimmaTech regains shigella shot from GSK, new CEO from CureVac
Jul 20, 2023 10:31am
CureVac posts mRNA flu, COVID-19 vaccine data in older adults
Jan 30, 2023 9:35am